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We have investigated the possibility that nitric oxide (NO) synthesis may affect the course of a trypanosome
infection via T-cell responses using mice deficient in inducible NO synthase (iNOS). Parasitemia levels in-
creased at the same rate in both iNOS-deficient homozygous and control heterozygous mice, and peak para-
sitemia values were the same in both groups. However, the heterozygous mice maintained higher parasitemia
levels after the peak of an infection than the homozygous mice due to a decrease in the rate of clearance of para-
sites. In iNOS-deficient mice there was an increase in the numbers of total CD41 cells and activated (inter-
leukin-2 receptor-expressing) CD41 cells in infected mice compared with the numbers in uninfected mice.
Spleen cells from infected iNOS-deficient mice displayed increased proliferative responses and gamma inter-
feron secretion when stimulated in vitro than those of control mice. These data suggest that NO production
depresses T-helper 1-like responses generated during Trypanosoma brucei infections, thus promoting the sur-
vival of the parasite.
Trypanosoma brucei infections cause African sleeping sick-
ness in humans and nagana in cattle. Infections are accompa-
nied by severe immunodepression in humans, domestic ani-
mals, and experimental rodent hosts, one facet of which is a
profound depression of lymphocyte responsiveness (2, 25). Im-
munodepression is mediated by activated “suppressor” macro-
phages (2, 5, 8, 13, 18, 20, 25). Lymphocyte unresponsiveness is
associated with depressed interleukin-2 (IL-2) and IL-2 recep-
tor expression (18, 20, 22) and is gamma interferon (IFN-g)
dependent (6). High levels of plasma IFN-g occur early in in-
fection (4), and one mechanism by which suppressor macro-
phages modulate lymphocyte function is via the activation
products nitric oxide (NO) and prostaglandins (13, 18, 20, 24).
In murine trypanosomiasis, therefore, NO causes damage to
the lymphocyte function of the host. Recent studies on human
and nonhuman primate infections with T. brucei suggest that
NO production is elevated to levels similar to those found in
the mouse infection model (26), although the functional sig-
nificance in terms of immunodepression has yet to be deter-
mined.
The NO synthesized by splenic and peritoneal macrophages
from trypanosome-infected mice has no trypanocidal activity
(31). Although the growth of T. brucei is prevented when the
organism is cocultured with activated macrophages or chemi-
cal donors of NO, trypanosomes in vivo are protected from any
toxic effects as a result of their bloodstream habitat, in which
hemoglobin acts as a sink for NO production (12). Inhibition of
NO synthase (NOS) activity in the host with chemical inhibi-
tors leads to reduced peak parasitemia levels (23). In T. brucei
infections, the obverse of the general paradigm of NO as an
antimicrobial effector is therefore observed.
Thus, there is clear evidence linking production of NO by
activated macrophages to depression of cellular responses.
There is also evidence linking NO production to changes in
parasitemia levels without a direct action of NO on the para-
sites themselves. The question as to whether the depression of
cellular responses causes increases in parasitemia therefore
arises. Manipulation of inducible NO synthase (iNOS) activity
in trypanosome-infected mice should enable this question to be
addressed. Previous attempts to test the effects of NO on par-
asitemia and the induction of anemia used inhibitors of NOS)
that suffered from a lack of specificity, as all isoforms were
inhibited and administration was tolerated by mice for only
limited periods (11, 23). In the present study we sought direct
evidence for the role of iNOS in immunodepression and levels
of T. brucei parasitemia using iNOS-deficient mice.
MATERIALS AND METHODS
Mice. iNOS-deficient mice were generated as described previously (32). Dis-
ruption of the murine iNOS gene was achieved by homologous recombination in
129sv embryonic stem cells. The recombinant allele was passed through the germ
line following the mating of the embryonic stem cell chimeras with MF-1 mice
(Harlan Ltd., Oxon, United Kingdom). The homozygous and heterozygous mice
thus generated were backcrossed with MF-1 mice for three generations. All the
mice used were from the matings of littermates and should therefore have had a
similar genetic background. Peritoneal cells from mutant mice did not produce
iNOS protein following activation by IFN-g and lipopolysaccharide in vitro as
judged by Western blotting. They also did not produce detectable amounts of
NO after being cultured for 48 h with IFN-g and lipopolysaccharide. By 72 h,
however, a low level of nitrite was detectable in the culture supernatant of cells
from the iNOS-deficient mice. This may reflect either the accumulation of nitrite
produced by constitutive NOS (14) or the induction of constitutive NOS (1, 17).
iNOS-Deficient mice remained competent for other aspects of macrophage func-
tion (14). Female mutant mice and their heterozygous littermates were used
when 8 to 10 weeks old. Because only mice with an outbred background were
available, all assays were conducted on individual mice to take into account the
potential genetic variability.
Trypanosomes. To initiate experimental infections, groups of five adult female
mice were inoculated with 104 trypanosomes/mouse via an intraperitoneal route
with the cloned pleomorphic trypanosome line GUTat (Glasgow University
Trypanozoon antigen type) 7.2. This line produces resolving infections in BALB/c
mice in which more than 95% of the population expresses the same variable
antigen type (VAT), GUTat 7.2, during the first wave of parasitemia (15). Two
other VATs used in this study, ILTat (ILRAD Trypanozoon antigen type) 1.3 and
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1.61, are not expressed during the first 15 days of infection of the GUTat 7.2 line.
In rabbits (which are less susceptible to infection than mice) these two VATs are
detected at approximately days 20 through 30 of infection (15, 27a). The para-
sitemia of each mouse was monitored daily by removing 2 ml of blood and
diluting it in 0.85% NH4Cl in phosphate-buffered saline (PBS), and parasites
were counted by using an Improved Neubauer hemocytometer.
To obtain parasites for ex vivo proliferation and cytokine assays, cloned try-
panosome lines that stably express GUTat 7.2, ILTat 1.3, or ILTat 1.61 were
grown in adult female CFLP mice (Harlan Olac) and purified from infected
mouse blood (9). Trypanosomes were suspended in 0.1 M PBS (pH 7.4) and
counted. They were then incubated at room temperature for 20 min in 4%
paraformaldehyde in PBS, washed three times in PBS by centrifugation at 900 3
g for 5 min each time, and left overnight in 0.1 M NH4Cl in PBS to neutralize
NH2 groups. The trypanosomes were centrifuged, resuspended in PBS at a
concentration of 107/ml, and stored at 4°C for up to 4 weeks. Populations were
checked for VAT homogeneity by immunofluorescence on air-dried smears fixed
in 70% ethanol by using VAT-specific antibodies as previously described (29).
Isolation of mononuclear splenocytes. Spleens were removed from individual
mice, and mononuclear splenocytes were isolated. Briefly, spleens were disrupted
through sterile tea strainers into RPMI 1640 medium and passed through 100-
mm-pore-size monofilament nylon filters to obtain single cell suspensions.
Cymelarsan (Rhone-Merieux, Lyon, France) was added to each suspension (in-
cluding controls) at 50 mg/ml to kill contaminating trypanosomes, and suspen-
sions from infected mice were monitored by microscopy until lysis of trypano-
somes was observed (usually 10 to 30 min). The splenocytes were centrifuged,
and loose pellets were resuspended, layered onto cushions of Nycoprep (Ny-
comed Ltd.), and centrifuged for 15 min at 700 3 g. The mononuclear interface
layer was removed and centrifuged, and the pellet was resuspended in 2 ml of
medium. The cells were counted, their viability was checked by trypan blue
exclusion, and the cells were resuspended at the required density. The centrif-
ugation steps after Cymelarsan treatment removed dead parasites from these
preparations, as judged by phase-contrast microscopy.
Flow cytometry analyses. From each spleen, aliquots of 106 mononuclear
splenocytes were made, resuspended in PBS with 5% fetal calf serum and 0.05%
azide in 50-ml volumes, and double-labelled with phycoerythrin (PE)-conjugated
anti-CD4 plus fluorescein isothiocyanate (FITC)-conjugated anti-CD8, PE-con-
jugated anti-CD4 plus FITC-conjugated anti-CD25a chain, or PE-conjugated
anti-CD8 plus FITC-conjugated anti-CD25a chain (Pharmingen) at the manu-
facturer’s recommended concentrations for 1 h on ice. The cells were washed
twice in PBS-fetal calf serum and resuspended in 0.1 M Tris–0.9% NH4Cl for 10
min to lyse any contaminating erythrocytes. The cells were pelleted by brief
centrifugation, resuspended in PBS (pH 7.0), and analyzed with a FACScan flow
cytometer (Becton Dickinson).
Proliferation assays. The isolated mononuclear splenocytes were plated out at
2 3 106 cells/well in 200-ml aliquots in flat-bottomed 96-well microtiter plates
with either medium alone, concanavalin A (ConA) (8 mg/well; Sigma), or para-
formaldehyde-fixed trypanosomes (2 3 106/ml) expressing GUTat 7.2, ILTat 1.3,
or ILTat 1.61. The cells were incubated at 37°C in 5% CO2 for 48 h and
radiolabelled with 1 mCi of [3H]thymidine per well for the last 16 h before being
harvested; results were read on a Betaplate counter. The proliferative responses
were determined by [3H]thymidine incorporation, and results are expressed as
the mean counts per minute (6 2 standard errors [SE]) of four wells.
Cytokine assays. The cells were dispensed into 24-well plates at 4 3 106
cells/well in 1.25-ml volumes and incubated with either medium alone, ConA
(8 mg/well), or paraformaldehyde-fixed trypanosomes (2 3 106/ml) expressing
GUTat 7.2, ILTat 1.3, or ILTat 1.61. The cells were incubated at 37°C in 5%
CO2, supernatants were harvested at 72 h and microcentrifuged for 30 s to
remove cells, and the cell-free supernatants were stored at 220°C until analysis
by enzyme-linked immunosorbent assay for IFN-g, IL-2, and IL-5 with commer-
cial capture and detection antibodies (Pharmingen).
Plasma nitrate levels. The levels of nitrite and nitrate present in the plasma
from individual mice were measured by the reduction of nitrate to nitrite and by
the Griess reaction as previously described (7, 12).
Statistical analyses. Parasitemia data were analyzed by repeated measures
analysis of variance with log-transformed data, and levels of IFN-g and plasma
nitrate were analyzed by Mann-Whitney U tests.
RESULTS
Each experiment was conducted at least twice and produced
the same pattern of data on each occasion.
Comparison of parasitemia levels in iNOS-deficient and
control mice. Levels of GUTat 7.2 parasitemia in iNOS-defi-
cient and control mice increased exponentially at similar rates
and reached similar densities at the peak of parasitemia on the
same day postinfection (Fig. 1). Parasitemic decline after the
parasitemic peak was different between the two groups (F1, 6 5
43.0, P , 0.001), however, with parasitemias in the iNOS-
deficient mice decreasing more rapidly. From days 8 to 11 of
infection there was an approximately 1-order-of-magnitude
difference in levels of parasitemia between iNOS-deficient and
control mice. These levels of parasitemia in the heterozygous
MF-1 mice were higher than those previously described for
BALB/c mice (30); therefore, these experiments were termi-
nated on day 11 of infection, and several components of the
immune system were assayed.
Cytometric analyses of mononuclear splenocytes. Express-
ing cytometric data in percentage terms fails to take into ac-
count the gross splenomegaly caused by trypanosomiasis; for
this reason, our data are expressed as cell numbers per spleen.
As a result of infection, CD41-cell numbers increased in
iNOS-deficient mice, and CD81-cell numbers decreased slight-
ly in both groups (Fig. 2). These changes caused the ratios of
CD41 cells to CD81 cells to change from 2:1 to 8:1 in iNOS-
deficient mice and from 3.8:1 to 7.3:1 in control mice. Figure 2
also shows that there were approximately fourfold more acti-
vated CD41 cells (expressing CD25) present in the spleens
from iNOS-deficient infected mice than in spleens from in-
fected control or uninfected mice. Activated CD81 cells were
detected only in mononuclear splenocyte populations (in low
numbers, 2 3 104/spleen) from infected iNOS-deficient mice.
Proliferative responses. The ability of the T cells to prolif-
erate in response to ConA was examined (Fig. 3). High levels
of proliferation were observed in splenocytes from infected
mice in the absence of any stimulant, which is in accord with
our previous observations, and we attribute these responses to
increased numbers of activated cells in infected mice (5). Nev-
ertheless, enhanced proliferation in response to ConA was
seen in control mice (2.9-fold higher) and, most notably, in the
iNOS-deficient mice (4.5-fold higher) (Fig. 3). Trypanosome-
specific proliferation in response to paraformaldehyde-fixed
parasites expressing one of the three VATs was not observed
(data not shown). We attribute the difference in ConA-induced
proliferative responses between iNOS-deficient and control
mice to the way in which they respond to infection rather than
to any intrinsic difference between the mice. No such differ-
ences were found between uninfected iNOS-deficient and con-
FIG. 1. Time course of T. brucei parasitemia in iNOS-deficient (E) and
heterozygous control (F) mice inoculated with 104 GUTat 7.2 parasites. Results
are expressed as geometric means 62 SE for groups of five mice.
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trol mice with an MF-1 genetic background in a previous
study (14). Also, negligible differences were found in a study
of iNOS-knockout mice with a C57BL/6 genetic background
(10).
Cytokine production. Mononuclear splenocytes from chron-
ically infected control and iNOS-deficient mice differed in the
capacity to produce IFN-g (Fig. 4). The control mice produced
very little IFN-g when stimulated with ConA or with any of the
three paraformaldehyde-fixed VATs. However, IFN-g produc-
tion by mononuclear splenocytes from the iNOS-deficient mice
was very different, with high levels produced in response to
ConA (W 5 15, P , 0.05) and trypanosomes expressing the
homologous, but not heterologous, VAT (W 5 15, P , 0.05).
The heterologous VATs, ILTat 1.3 and 1.61, were both unde-
tectable by immunofluorescence analysis on days 7 and 11 of
infection (data not shown), indicating that splenocytes had no
detectable exposure to these VATs in vivo. The three trypano-
some lines used to stimulate the mononuclear cells are of the
same genetic origin and thus differ antigenically only in their
VAT expression. All antigens except the variant surface glyco-
proteins (VSGs) (the invariant antigens) were thus the same in
all three paraformaldehyde-fixed preparations. If invariant an-
tigens were strongly immunogenic in this assay, then equivalent
levels of IFN-g production would be expected, irrespective of
which antigen preparation was used as a stimulant. A similar
result would also be expected if the three VSGs shared epi-
topes. The data shown in Fig. 4 thus confirm that VSG is the
FIG. 2. Numbers of CD41 (light) or CD81 (dark) cells per spleen (A) and
numbers of activated CD41 (light) or CD81 (dark) cells per spleen, with CD25
as a marker for cell activation (B). Numbers were determined by flow cytometry
of mononuclear splenocytes of iNOS-deficient (2/2) and control (1/2) mice,
either uninfected or infected with GUTat 7.2 (results are for day 11 of infection).
Mononuclear splenocytes were counted, the lymphocyte population was gated
and checked to exclude autofluorescence, and relative numbers were deter-
mined. From these data, cell numbers per spleen were calculated and are ex-
pressed as geometric means 62 SE for groups of five mice.
FIG. 3. Proliferative responses of mononuclear splenocytes from trypano-
some-infected iNOS-deficient (2/2) (dark) and control (1/2) (light) mice
harboring infections of GUTat 7.2. Splenocytes were cultured in the presence
of either medium or ConA (8 mg/ml). Proliferative responses of mononuclear
splenocytes from uninfected mice were ,2,000 cpm in the absence of stimula-
tion. Results are expressed as the geometric means 62 SE for groups of five
mice.
FIG. 4. IFN-g production by mononuclear splenocytes from iNOS-deficient
mice and their heterozygous counterparts harboring infections with GUTat 7.2.
IFN-g concentrations were assayed by enzyme-linked immunosorbent assay.
Cells were stimulated with medium, ConA (8 mg/ml), or paraformaldehyde-fixed
trypanosomes (2 3 106/ml) expressing the homologous VAT or one of the two
heterologous VATs. Supernatants were harvested 72 h after stimulation. Results
are expressed as means 62 SE for groups of five mice.
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main immunogen of T. brucei and indicate VAT-specific stim-
ulation of IFN-g production.
In both control and iNOS-deficient infected mice, IL-5 pro-
duction was ,1 U/ml when stimulated with medium, ConA, or
any of the three VATs (data not shown). The only detectable
IL-2 production was from cells stimulated with ConA. These
levels, in both groups of mice, were ,10 U/ml 24 h after
stimulation in vitro (data not shown).
Plasma nitrite and nitrate. In control and iNOS-deficient
uninfected mice, the mean concentrations of nitrate (62 SE)
were 24.7 6 4.1 and 18.8 6 2.9 mM, respectively. In the in-
fected control mice there was a 6.7-fold increase in plasma
nitrate levels, to 165.0 6 45.3 mM (W 5 49, P 5 0.023), and a
3.8-fold increase in the iNOS-deficient infected mice, to 70.8 6
7.9 mM (W 5 56, P 5 0.011).
DISCUSSION
Abrogation of iNOS activity had a marked affect on all
indices of T-cell competence. Numbers of splenic CD41 cells
and activated CD41 cells expressing the IL-2 receptor in-
creased as a result of infection in the iNOS-deficient mice,
whereas CD81 cell numbers decreased and CD25 CD8 dou-
ble-positive cells occurred only rarely. These data are consis-
tent with previous observations that the T-cell response in T.
brucei infection is mainly CD4 mediated (19) rather than CD8
mediated (3, 16). These data are also in agreement with the
observation of a proliferative response to ConA and of the
ability to generate IFN-g, but not IL-5, in response to both
ConA and specific antigen, indicating that there is a depression
of T-cell responses (2, 5, 6, 8, 13, 18, 20, 22, 25) caused by NO
and that responsiveness is restored on removal of NO (13, 18,
23, 24). The extent of the recovery of T-cell competence in the
iNOS-deficient mice was sufficient to cause a change in para-
sitemia but has not been determined directly. A prediction
would be that the recovery was incomplete, given that we
observed raised levels of plasma nitrate in the iNOS-deficient
mice and as a result of continued immunodepressive prosta-
glandin synthesis (18, 21). This prediction is consistent with our
observation of trypanosome VAT-specific responsiveness de-
tected by the IFN-g assay but proliferative responsiveness de-
tected only with mitogen. IFN-g production in the absence of
a proliferative response has been previously observed in peri-
toneal T cells from T. brucei-infected mice (19). Our results
suggest that on day 11 of infection in this mouse model there
was a generalized depression of T-cell responses, but a defi-
ciency in NO production restored some cellular competence.
The observation that the numbers of splenic CD41 cells and
activated CD41 cells increased in iNOS-deficient mice, to-
gether with the detection of IFN-g, but not IL-5, production
from splenocytes, suggests that the cellular response is
T-helper 1-like.
Our parasitology data contrast with the results from studies
using NOS inhibitors, which showed a reduction in peak levels
of parasitemia but no difference in rates of parasite clearance
(23). This discrepancy may be due to the use of different mouse
and parasite strains but also may reflect levels and sources of
NO. NG-nitro-L-arginine methyl ester (L-NAME) causes a
quantitative reduction in NO production by all isoforms of
NOS, whereas in the present study iNOS activity was abro-
gated but other isoforms were unaffected. We have some evi-
dence for compensatory production of NO from a source other
than iNOS in the elevated levels of plasma nitrate in the
infected iNOS-deficient mice. A low level of production of NO
has been observed previously in culture supernatants of peri-
toneal cells from these iNOS-deficient mice (14). These ele-
vated levels of nitrate may reflect the induction of constitutive
isoforms of NOS, as has been demonstrated under other cir-
cumstances (1, 17).
It has been suggested that while NO is a mediator of immu-
nodepression in mice, it is not so in cattle (27). However, most
of the murine studies have been conducted with T. brucei,
whereas the cattle study was based on Trypanosoma congo-
lense, and these two species differ in an important aspect of
their biology. T. congolense parasites adhere to the vascular
endothelium whereas T. brucei does not. Macrophage activa-
tion happens mainly in the spleen and liver, but the rate of
movement of trypanosomes through these organs is expected
to be considerably lower for T. congolense. Thus, the quanti-
tative extent, and perhaps qualitative nature, of macrophage
activation would be expected to be very different for the two
species. Studies on T. congolense-infected iNOS-deficient mice
are clearly warranted.
Our results suggest that as a result of NO production, par-
asitemia levels declined more slowly after the first peak and
indices of cellular responsiveness were lower. Establishing this
link between depression and a higher level of parasitemia after
the first peak is important because it has been postulated that
the generation of immunodepression is an immune evasion
strategy (2). This postulate can only be true, however, if de-
pression is of selective advantage to the parasite (in evolution-
ary terms) rather than merely disadvantageous to the host (28).
It is only by increasing the level of parasitemia, and thus pro-
moting transmission of parasites from mammals to the tsetse
fly, that a selective advantage can be obtained. The implication
from our data is that trypanosomes contain genetically deter-
mined mechanisms for causing immunodepression.
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